← Eichor
Study identifier: NCT06831396 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effectiveness of Ultrasound-Aided Articulation Therapy for Children With Speech Sound Disorders

Condition: Speech Sound Disorder  ·  Sponsor: The University of Hong Kong

PhaseNA
Planned participants60
Who can joinAll sexes, 5 Years to 12 Years
Healthy volunteersNo

About this study

This prospective randomized controlled trial investigates the effect of ultrasound visual biofeedback as an adjunct to articulation therapy in children with speech sound disorders involving lingual targets. The intervention aims to facilitate acquisition of misarticulated sounds by providing real-time visualization of tongue movements. Participants are randomized 1:1 to immediate treatment or wait-list control, with stratification by disorder type, age, and gender where feasible. The wait-list control group continues usual care for 4 weeks before crossing over to receive the same intervention (ethical crossover design).

This description comes directly from the study's public registry record.

Talk to the study team

Oi Yan Yoyo Yiu  ·  5741 3431  ·  h0501126@connect.hku.hk

Always discuss trial participation with your own doctor first.

Locations (1)

Hong Kong Children's Hospital and Child Assessment Centre of The Duchess of Kent Children's HospitalHong Kong, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06831396